Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New diacylglycerol O-acyltransferase 1 inhibitors patented

June 1, 2011

EMA accepts for review Savient Pharmaceuticals' MAA for Krystexxa

May 30, 2011

Ellavie spray approved in Sweden to treat symptoms of menopause

May 27, 2011

NHLBI stops AIM-HIGH study of niacin added to simvastatin early

May 27, 2011

HRA Pharma and ASKA Pharmaceutical enter licensing agreement in Japan for ellaOne

May 27, 2011

Metabolex begins phase II trial of arhalofenate in patients with gout

May 26, 2011

New selective glucocorticoid receptor antagonists prevent olanzapine-induced weight gain in vivo

May 26, 2011

Radius Health provides update on BA-058 formulations for osteoporosis

May 26, 2011

Pfizer designs new sodium/glucose cotransporter 2 inhibitors

May 25, 2011

New free fatty acid FFA1 receptor agonists disclosed

May 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...